Efficacy/effectiveness and safety of emicizumab prophylaxis of people with hemophilia A: a systematic review and meta-analysis.
Roberto Lúcio MunizRicardo Mesquita CameloMaiara Silva AraújoMariana Michel BarbosaAugusto Afonso GuerraFrancisco de Assis AcurcioJuliana Alvares-TeodoroPublished in: Expert review of hematology (2023)
Emicizumab prophylaxis was superior in reducing the ABR-all when compared with prophylaxis with FVIII or BPA.
Keyphrases